ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $737,092 | +88.2% | 20,670 | +34.1% | 0.81% | +69.0% |
| Q1 2023 | $391,617 | -64.0% | 15,418 | -42.6% | 0.48% | -54.9% |
| Q4 2022 | $1,089,158 | +60.2% | 26,853 | +20.8% | 1.06% | +57.2% |
| Q3 2022 | $680,000 | -0.7% | 22,235 | +14.4% | 0.68% | +7.0% |
| Q2 2022 | $685,000 | -6.5% | 19,444 | +22.0% | 0.63% | +18.8% |
| Q1 2022 | $733,000 | +184.1% | 15,933 | +309.3% | 0.53% | +199.4% |
| Q4 2021 | $258,000 | -96.2% | 3,893 | -95.6% | 0.18% | -89.3% |
| Q4 2020 | $6,766,000 | -11.8% | 88,183 | -50.5% | 1.66% | -27.0% |
| Q3 2020 | $7,673,000 | -0.3% | 178,183 | 0.0% | 2.27% | -11.5% |
| Q2 2020 | $7,696,000 | +216.4% | 178,183 | +110.8% | 2.57% | +151.7% |
| Q1 2020 | $2,432,000 | – | 84,537 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |